C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2004
11/24/2004	EP1183279B1 Polymerization of ethylene
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1033965B1 Agents and method for producing semi-permanent colorations of keratin fibers
11/24/2004	EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004	CN1549820A Activators for oligonucleotide synthesis
11/24/2004	CN1549811A Ortho-substituted aryl amides for controlling invertebrate pests
11/24/2004	CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004	CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004	CN1177002C Antimicrobial composition
11/24/2004	CN1176908C Process for producing pyridine derivate
11/24/2004	CN1176907C Substituted pyridine herbicides
11/23/2004	US6822114 Alkylating p-halo-o-hydrocarbyloxyphenol with monohaloalkane; carbonylation with carbon monoxide to obtain 3,4-disubstituted benzoyl compound; etherification
11/23/2004	US6822096 Colorimetric analysis; reversible adsorption/desorption of vapor of acetonitrile or ethanol; red/infrared change in luminescence
11/23/2004	US6822093 Reacting 2-iodo-5-bromo -pyridine or -pyrimidine with an alkylmagnesium halide grignard reagent and reacting the product with an electrophilically-substituted aryl or heteroaryl compound (e.g., methylenedimorpholine)
11/23/2004	US6821992 Fungicides
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	CA2347374C Preparation of chloromethylpyridine hydrochlorides
11/23/2004	CA2330942C Piperazine derivatives and process for the preparation thereof
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004	WO2004099340A1 Luminescent-polymer composition
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099158A1 Monocyclic diazodioxide based bcl-2 protein antagonists
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099149A1 Processes for producing 3-substituted 2-chloro-5fluoropyridine or salt thereof
11/18/2004	WO2004099148A1 Substituted pyrimidine derivatives
11/18/2004	WO2004099146A1 Benzamide inhibitors of the p2x7 receptor
11/18/2004	WO2004099128A1 Method for synthesizing metal complex
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004098584A1 Peptide deformylase inhibitors
11/18/2004	WO2004072026B1 Process for preparing pyridine-substituted amino ketal derivatives
11/18/2004	WO2004069803A3 Mono-acylated o-phenylendiamines derivatives and their use against cancer
11/18/2004	WO2004063160A8 Novel quaternary ammonium salt compound having antibacterial activity and process for producing the same
11/18/2004	US20040230072 Phosphodiesterase 4 inhibitors
11/18/2004	US20040230058 Avoids over arylation and harmful reagents; industrial scale, high yield, purity
11/18/2004	US20040230055 Using alkylmetal reagents for directed metalation of azaaromatics
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229952 a thiohydrazide product compound prepared by reacting a hydrazide starting compound with a thionylating reagent; anticancer agents
11/18/2004	US20040229937 diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
11/18/2004	US20040229935 Cytotoxic compounds
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229920 Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
11/18/2004	US20040229919 As diuretic agent, as an agent for preventing heart or heart tissue damages caused by metabolic or ionic abnormalities associated with ischemia, in the treatment of thrombosis, angina pectoris, asthma, hypertension, nephroedema, pulmonary edema, primary and secondary aldosteronism, Bartter's syndrome
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229904 Compounds useful for the treatment of diseases
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	CA2525190A1 Intermediate compound which is used for the preparation of pioglitazone
11/18/2004	CA2524352A1 Substituted pyrimidine derivatives
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477485A1 Aminophenol derivatives
11/17/2004	EP1477484A1 Oxonol dye compound, optical information recording medium using the same, and optical information
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477167A1 [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476428A1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1317455B9 Process for preparing a substituted imidazopyridine compound
11/17/2004	EP1296983B1 Novel process for the preparation of pyrazolopyrimidinones
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1546471A Pyridyl tetraquinone molecular material and its preparing process
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546462A Insecticidal antibacterial sulphur , oxygen and oxime-containing ether compounds
11/17/2004	CN1546446A Fluorene derivatives and their application
11/17/2004	CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/16/2004	US6818787 Prodrugs of GABA analogs, compositions and uses thereof
11/16/2004	US6818773 Synthesis of 4-[(Z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbony)]-4'-methyl-1,4-′bipiperidine
11/16/2004	US6818715 Ligand system for novel complexes containing late transition metals which can be used for polymerization of unsaturated compounds and give branched polymers
11/16/2004	US6818666 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
11/16/2004	US6818661 Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors
11/16/2004	US6818660 Calcilytic compounds
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004	CA2116003C Arylalkanoic acid resolution
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096772A1 Novel process for the preparation of 2-aminomethylpyridine derivatives
11/11/2004	WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor
11/11/2004	WO2004096755A1 Platinum complex
11/11/2004	WO2004096135A2 Inhibitors of akt activity
11/11/2004	WO2004080376A3 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004075864A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors

1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 633